MiNK Therapeutics, Inc. (INKT) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$10.80
+1.60%
Mkt Cap $55.32M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | — | — | — | -$0.68 | -$0.52 | +23.53% |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.86 | -$0.65 | +24.42% |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.55 | -$1.06 | -92.73% |
| Q2 2025 May 15, 2025 | — | — | — | -$0.61 | -$0.70 | -14.75% |
| Q1 2025 Mar 18, 2025 | — | — | — | -$0.50 | -$0.62 | -24.00% |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.80 | -$0.50 | +37.50% |
| Q3 2024 Aug 13, 2024 | — | — | — | -$1.00 | -$0.70 | +30.00% |
| Q2 2024 May 14, 2024 | — | — | — | -$1.60 | -$1.10 | +31.25% |
| Q1 2024 Mar 21, 2024 | — | -$11.71B | — | -$1.50 | -$1.60 | -6.67% |
| Q4 2023 Nov 9, 2023 | — | — | — | -$1.80 | -$1.50 | +16.67% |
| Q3 2023 Aug 10, 2023 | — | — | — | -$1.90 | -$1.80 | +5.26% |
| Q2 2023 May 11, 2023 | — | $11.71B | — | -$2.40 | -$1.70 | +29.17% |
| Q1 2023 Mar 21, 2023 | — | $2.70B | — | -$2.10 | -$2.30 | -9.52% |
| Q4 2022 Nov 3, 2022 | — | $1.56B | — | -$2.30 | -$1.90 | +17.39% |
| Q3 2022 Aug 9, 2022 | — | $1.56B | — | -$2.40 | -$1.80 | +25.00% |
| Q2 2022 May 10, 2022 | — | — | — | -$2.10 | -$2.30 | -9.52% |
| Q1 2022 Mar 18, 2022 | — | $221.92M | — | -$2.40 | -$1.80 | +25.00% |
| Q4 2021 Nov 29, 2021 | — | — | — | -$0.20 | -$0.59 | -195.00% |
| Q4 2021 Oct 15, 2021 | — | — | — | — | -$0.22 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.14 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.05 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.21 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.18 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.18 | — |